Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
54
ELV Quote, Financials, Valuation and Earnings
Last price:
$372.90
Seasonality move
:
9.84%
Day range:
$372.35 - $378.28
52-week range:
$273.71 - $458.75
Dividend yield:
1.84%
P/E ratio:
15.25x
P/S ratio:
0.43x
P/B ratio:
1.89x
Volume:
887.3K
Avg. volume:
1.5M
1-year change:
-2.72%
Market cap:
$82.9B
Revenue:
$176.8B
EPS (TTM):
$24.45
Analysts' Opinion
-
Consensus RatingElevance Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $393.95, Elevance Health, Inc. has an estimated upside of 5.67% from its current price of $372.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $320.00 representing 14.17% downside risk from its current price of $372.83.
Fair Value
-
According to the consensus of 17 analysts, Elevance Health, Inc. has 5.67% upside to fair value with a price target of $393.95 per share.
ELV vs. S&P 500
-
Over the past 5 trading days, Elevance Health, Inc. has overperformed the S&P 500 by 3.62% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Elevance Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Elevance Health, Inc. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Elevance Health, Inc. reported revenues of $50.7B.
Earnings Growth
-
Elevance Health, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Elevance Health, Inc. reported earnings per share of $5.32.
Enterprise value:
115.1B
EV / Invested capital:
--
Price / LTM sales:
0.43x
EV / EBIT:
16.21x
EV / Revenue:
0.59x
PEG ratio (5yr expected):
9.29x
EV / Free cash flow:
30.55x
Price / Operating cash flow:
22.46x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
4.62%
Net Income Margin (TTM):
2.84%
Return On Equity:
12.81%
Return On Invested Capital:
7.52%
Operating Margin:
3.47%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $168.6B | $174B | $194.8B | $45.1B | $50.7B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $8.8B | $9.2B | $8.5B | $1.7B | $1.8B | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $25.13 | $27.43 | $24.45 | $4.36 | $5.32 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $51.9B | $55.6B | $61.2B | $62.8B | $63.8B | |
| Total Assets | $98.1B | $103B | $110.5B | $116.5B | $122.7B | |
| Current Liabilities | $35.2B | $41.3B | $43.3B | $42B | $40.9B | |
| Total Liabilities | $62.3B | $67B | $71.9B | $72.7B | $78.7B | |
| Total Equity | $35.8B | $36B | $38.5B | $43.9B | $44.1B | |
| Total Debt | $23.6B | $24.4B | $25.7B | $26.8B | $31.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9.5B | $2.1B | $4.9B | $2.7B | $1.1B | |
| Cash From Investing | -$4.3B | -$4.6B | -$3.4B | -$401M | -$1.2B | |
| Cash From Financing | -$3.2B | -$609M | -$566M | -$915M | $243M | |
| Free Cash Flow | $8.2B | $871M | $3.8B | $2.3B | $775M | |
ELV
Sector
Market Cap
$82.9B
$28.1M
Price % of 52-Week High
81.27%
51.87%
Dividend Yield
1.84%
0%
Shareholder Yield
6.31%
-1.59%
1-Year Price Total Return
-2.72%
-17.31%
Beta (5-Year)
0.514
0.495
Dividend yield:
1.84%
Annualized payout:
$6.52
Payout ratio:
32.17%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$362.85
200-day SMA
Buy
Level
$352.02
Bollinger Bands (100)
Buy
Level
314.55 - 350.75
Chaikin Money Flow
Buy
Level
313.9M
20-day SMA
Buy
Level
$354.75
Relative Strength Index (RSI14)
Buy
Level
68.43
ADX Line
Buy
Level
19.15
Williams %R
Sell
Level
-16.1229
50-day SMA
Buy
Level
$337.17
MACD (12, 26)
Buy
Level
8.85
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
152M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9933)
Buy
CA Score
(Annual)
Level (-0.1905)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.9188)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Stock Forecast FAQ
In the current month, ELV has received 10 Buy ratings 7 Hold ratings, and 0 Sell ratings. The ELV average analyst price target in the past 3 months is $393.95.
-
Where Will Elevance Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Elevance Health, Inc. share price will rise to $393.95 per share over the next 12 months.
-
What Do Analysts Say About Elevance Health, Inc.?
Analysts are divided on their view about Elevance Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Elevance Health, Inc. is a Sell and believe this share price will drop from its current level to $320.00.
-
What Is Elevance Health, Inc.'s Price Target?
The price target for Elevance Health, Inc. over the next 1-year time period is forecast to be $393.95 according to 17 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is ELV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Elevance Health, Inc. is a Buy. 10 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ELV?
You can purchase shares of Elevance Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Elevance Health, Inc. shares.
-
What Is The Elevance Health, Inc. Share Price Today?
Elevance Health, Inc. was last trading at $372.90 per share. This represents the most recent stock quote for Elevance Health, Inc.. Yesterday, Elevance Health, Inc. closed at $372.83 per share.
-
How To Buy Elevance Health, Inc. Stock Online?
In order to purchase Elevance Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ELV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ELV
Sector
P/E ratio
15.25x
24.20x
PEG ratio
9.29x
-0.01x
P/B ratio
1.89x
1.84x
Price / LTM sales
0.43x
1.60x
Growth Metrics
ELV
Sector
Revenue growth
12.33%
4.51%
Earnings growth
21.95%
10.7%
Revenue (5-year growth)
11.15%
6.45%
Earnings forecast
$3.09
-$0.19
Profitability
ELV
Sector
Profitability FY 2024
--
$3.5M
Return on invested capital
7.52%
-32.3%
Return on assets
4.62%
-28.57%
Return on equity
12.81%
-38.09%
Earnings Date
Last Earnings Date
Oct
21
Next Earnings Date
Jan
28
Estimated Next Earnings Date
Jan
20
Balance Sheet
ELV
Sector
Total cash
$33.9B
$26M
Short term investments
$25.2B
$25.7M
Total assets
$116.9B
$76.4M
Long term debt
$31.9B
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
